2000 Biological New Drug Application (NDA) Approvals
This list reflects information regarding the application as of the approval date; it is not updated with regard to applicant or application status changes.
Tradename/ Established Name |
Indication for Use | Applicant | Approval Date |
---|---|---|---|
None Anticoagulant Sodium Citrate 4% w/v Solution, USP |
Use only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures | Haemonetics Corp 400 Wood Road Braintree, MA 02184 |
3/3/2000 |